Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Explore Kanna: A Legal Psychoactive Plant Ally in Turbulent Times

PT462 – Touch Therapy, Wearable Technology, and Treating Trauma with Safety

Pα+ Mini Interview with Eddie Jacobs: Post-Trial Provisions in Clinical Psychedelic...

Pα+ Mini Interview with Ester Kincová and Steve Rolles: Regulating the...

Pα+ Psychedelic Bulletin #149: Worldwide Psychedelic Policy Developments

Harming While Healing?: The Oppressive Nature of Psychedelic-Centric Drug Policy

PT461 – Holding Space, Hypnotherapy and Psychedelics, and the Importance of...

PT460 – Psychedelics in Film, Drugs as Bases and Modifiers, and...

The Psychedelic News Feed: Oct 9 – Nov 5, 2023

1...373839...218 Page 38 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin